Michał Maczewski is an expert in Cardiology at Institute of Cardiology (Poland) (Poland). Michał Maczewski has authored 68 publications, the most recent in 2026. SLR score: 212 (community average: 125). How the SLR is computed.

LeadR Profile

Michał Maczewski Institute of Cardiology (Poland) Poland
212 ScienceLeadR Reputation 212
Network Map

Cardiology

Subspecialties: Pharmacy - Geriatrics - Histology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Medical University of Warsaw

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 68

Citations

Citations: 1 189 1st author: 11 Last author: 19 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Exerkine dysregulation links visceral adiposity to skeletal muscle impairment in end-stage heart failure with reduced ejection fraction: proteomic evidence for a cardio-adipose-muscle axis.
PMID 42192415 — exercise, muscles, psoas muscles, leptin, heart failure, heart, stress, physiological, adiposity, heart failure, systolic, myostatin, muscle, skeletal, frailty, tissues, diabetes complications, adipose tissue
Cardiovasc Diabetol20260
Endothelial Cell Senescence and Mitochondrial Dysfunction in Vascular Ageing.
PMID 41935581 — cells, aging, stress, physiological, cellular senescence, mitochondria, endothelial cells, endothelium
Ageing Res Rev20260
Epicardial adipose tissue as a determinant of heart failure prognosis: insights across ejection fraction phenotypes.
PMID 41803855 — heart failure, heart, phenotype, tissues, diabetes complications, prognosis, adipose tissue
Cardiovasc Diabetol20260
Epicardial fat remodeling in end-stage heart failure with reduced ejection fraction.
PMID 41692740 — cells, cell size, heart failure, heart, adipocytes, myocardium, heart failure, systolic, therapeutics
Cardiovasc Diabetol20260
Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma - a mechanism of coronary flow impairment at the capillary level.
PMID 40972551 — blood viscosity, blood, capillaries, cardiovascular system, multiple myeloma
Cardiovasc Res20250

LeadR Networks

Main global connection map